Topics

Pediatric CNS tumors | Treatment | Targeted therapy | WP1066

Home > Publications > Topics > Pediatric CNS tumors > Treatment > Targeted therapy > WP1066

Castellino RC, Mumme HL, Franson AT, Yu B, Robinson MH, Dhodapkar K, Aguilera D, Schniederjan MJ, Keesari R, He Z, Bhasin M, Priebe W, Heimberger AB, MacDonald TJ.
First-in-child phase I trial of p-STAT3 inhibitor WP1066 in pediatric brain tumor patients.
JCI Insight. 2025 Dec 11:e194823. doi: 10.1172/jci.insight.194823. PMID: 41379553. Interventional study. ˍ